Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

PAPAVERINE IN CEREBRAL ANGIOSPASM (VASCULAR ENCEPHALOPATHY)

PAPAVERINE IN CEREBRAL ANGIOSPASM (VASCULAR ENCEPHALOPATHY) Papaverine relaxes many smooth muscles of the body, especially those of the blood vessels. Its therapeutic value has been demonstrated in arterial embolism, in which the drug increases collateral circulation by acting on reflexly constricted vascular channels. Similar therapeutic effect has recently been claimed from its use in angina pectoris and myocardial infarction. Indeed, the experimental and clinical observations of Katz1 would indicate that papaverine enhances coronary blood flow in these disease states. The action of papaverine on disturbances of the cerebral circulation has not thus far been reported. Embolism of the cerebral vessels would appear to be an indication for its use. The possible benefit from this drug in the therapy of angiospastic cerebral phenomena commonly observed in the course of hypertensive disease, acute glomerulonephritis, eclampsia gravidarum and lead poisoning has attracted the interest of the writers. The cerebral manifestations encountered in these conditions vary widely. In the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

PAPAVERINE IN CEREBRAL ANGIOSPASM (VASCULAR ENCEPHALOPATHY)

JAMA , Volume 136 (14) – Apr 3, 1948

Loading next page...
 
/lp/american-medical-association/papaverine-in-cerebral-angiospasm-vascular-encephalopathy-hNleTWDp2m
Publisher
American Medical Association
Copyright
Copyright © 1948 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1948.02890310022007
Publisher site
See Article on Publisher Site

Abstract

Papaverine relaxes many smooth muscles of the body, especially those of the blood vessels. Its therapeutic value has been demonstrated in arterial embolism, in which the drug increases collateral circulation by acting on reflexly constricted vascular channels. Similar therapeutic effect has recently been claimed from its use in angina pectoris and myocardial infarction. Indeed, the experimental and clinical observations of Katz1 would indicate that papaverine enhances coronary blood flow in these disease states. The action of papaverine on disturbances of the cerebral circulation has not thus far been reported. Embolism of the cerebral vessels would appear to be an indication for its use. The possible benefit from this drug in the therapy of angiospastic cerebral phenomena commonly observed in the course of hypertensive disease, acute glomerulonephritis, eclampsia gravidarum and lead poisoning has attracted the interest of the writers. The cerebral manifestations encountered in these conditions vary widely. In the

Journal

JAMAAmerican Medical Association

Published: Apr 3, 1948

There are no references for this article.